266 related articles for article (PubMed ID: 22576620)
1. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
[TBL] [Abstract][Full Text] [Related]
2. Anti-U3 RNP autoantibodies in systemic sclerosis.
Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
4. Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
Nandiwada SL; Peterson LK; Mayes MD; Jaskowski TD; Malmberg E; Assassi S; Satoh M; Tebo AE
J Rheumatol; 2016 Oct; 43(10):1816-1824. PubMed ID: 27481902
[TBL] [Abstract][Full Text] [Related]
5. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
6. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors.
McNearney TA; Reveille JD; Fischbach M; Friedman AW; Lisse JR; Goel N; Tan FK; Zhou X; Ahn C; Feghali-Bostwick CA; Fritzler M; Arnett FC; Mayes MD
Arthritis Rheum; 2007 Mar; 57(2):318-26. PubMed ID: 17330281
[TBL] [Abstract][Full Text] [Related]
8. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
9. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.
Reveille JD; Fischbach M; McNearney T; Friedman AW; Aguilar MB; Lisse J; Fritzler MJ; Ahn C; Arnett FC;
Semin Arthritis Rheum; 2001 Apr; 30(5):332-46. PubMed ID: 11303306
[TBL] [Abstract][Full Text] [Related]
11. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
Sharif R; Fritzler MJ; Mayes MD; Gonzalez EB; McNearney TA; Draeger H; Baron M; ; Furst DE; Khanna DK; del Junco DJ; Molitor JA; Schiopu E; Phillips K; Seibold JR; Silver RM; Simms RW; ; Perry M; Rojo C; Charles J; Zhou X; Agarwal SK; Reveille JD; Assassi S; Arnett FC
J Rheumatol; 2011 Aug; 38(8):1622-30. PubMed ID: 21572159
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological features of systemic sclerosis in a Chinese cohort.
Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
[TBL] [Abstract][Full Text] [Related]
15. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
[TBL] [Abstract][Full Text] [Related]
19. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
Morgan ND; Shah AA; Mayes MD; Domsic RT; Medsger TA; Steen VD; Varga J; Carns M; Ramos PS; Silver RM; Schiopu E; Khanna D; Hsu V; Gordon JK; Gladue H; Saketkoo LA; Criswell LA; Derk CT; Trojanowski MA; Shanmugam VK; Chung L; Valenzuela A; Jan R; Goldberg A; Remmers EF; Kastner DL; Wigley FM; Gourh P; Boin F
Medicine (Baltimore); 2017 Dec; 96(51):e8980. PubMed ID: 29390428
[TBL] [Abstract][Full Text] [Related]
20. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
